Renovorx to participate in fireside chat at the a.g.p. virtual healthcare company showcase on may 21, 2024

Los altos, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that shaun bagai, chief executive officer, will participate in a fireside chat at alliance global partners (a.g.p.) virtual healthcare company showcase hosted by scott henry, managing director and healthcare analyst at a.g.p. the event will be held on tues.
RNXT Ratings Summary
RNXT Quant Ranking